通过模拟试验激活提升招募准备:ASAP试验
本研究对休眠中的大流行流感临床试验ASAP进行模拟激活,测试试验流程并评估模拟对维持试验准备状态的价值。模拟涉及诺丁汉临床试验中心、一家参与医院、一个生产单位和IMP供应商,结果显示休眠试验按计划在唤醒后4周内成功激活并完成患者招募,同时发现人员缺勤应对和IMP库存控制系统的问题,模拟成本估计为1995英镑。
要点
- 模拟激活可在4周内完成休眠试验的患者招募。
- 需增强对关键试验程序中人员缺勤的应对能力。
- IMP库存控制系统存在可能影响随机化序列的潜在错误。
核心结论
- 模拟激活可作为测试和准备休眠研究快速激活的有用手段。
- 模拟练习能否减少复杂临床试验研究的浪费值得进一步探索。
研究设计与样本
- 对休眠中的大流行流感临床试验ASAP进行模拟激活,涉及诺丁汉临床试验中心、一家参与医院、一个生产单位和IMP供应商。
- 模拟时间为2015年9月15日至2015年12月2日,参与站点临床人员完成试验培训包,招募一名志愿者作为患者,开具「 dummy」IMP并完成随访。
主要发现
- 成功证明休眠试验按计划在唤醒后4周内激活并完成患者招募。
- 发现需增强对人员缺勤的应对能力,尤其在高延迟风险的关键试验程序方面。
- IMP库存控制系统被指出是可能 compromise 随机化序列的潜在错误来源。
- 模拟练习受到站点研究者的好评,并增加了他们对试验激活时满足可能需求的信心。
- 模拟练习的估计成本为1995英镑,其中90%为人员成本。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research in public health emergencies requires trials to be set up in readiness for activation at short notice and in anticipation of limited timelines for patient recruitment. We conducted a simulated activation of a hibernating pandemic influenza clinical trial in order to test trial processes and to determine the value of such simulation in maintaining trial readiness. METHODS: The simulation involved the Nottingham Clinical Trials Unit, one participating hospital, one manufacturing unit and the Investigational Medicinal Product (IMP) supplier. During the exercise, from 15 September 2015 to 2 December 2015, clinical staff at the participating site completed the trial training package, a volunteer acting as a patient was recruited to the study, 'dummy' IMP was prescribed and follow-up completed. RESULTS: Successful activation of the hibernating trial with patient recruitment within 4 weeks of 'arousal' as planned was demonstrated. A need for greater resilience in anticipation of staff absenteeism was identified, particularly in relation to key trial procedures where the potential for delay is high. A specific issue relating to the IMP Stock Control System was highlighted as a potential source of error that could compromise the randomisation sequence. The simulation exercise was well received by site investigators and increased their confidence in being able to meet the likely demands of the trial when activated. The estimated cost of the exercise was £1995; 90% of this being staff costs. CONCLUSIONS: Simulated activation is useful as a means to test, and prepare for, the rapid activation of 'hibernating' research studies. Whether simulation exercises can also help reduce waste in complex clinical trial research deserves further exploration. TRIAL REGISTRATION: EudraCT Number 2013-001051-12, ISRCTN72331452 . Registered on 6 March 2013.
引用
- Lim WS, Meakin G, Brittain C, et al. Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial. Trials. 2017. PMID: 29145878. doi:10.1186/s13063-017-2290-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。